Literature DB >> 6309369

Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase.

J H Doroshow.   

Abstract

This study investigated the effect of the anthracycline antibiotics on oxygen radical metabolism by cardiac mitochondrial reduced nicotinamide adenine dinucleotide (NADH) dehydrogenase [NADH:(acceptor) oxidoreductase, EC 1.6.99.3]. Superoxide formation by NADH dehydrogenase after anthracycline treatment appeared to follow saturation kinetics with an apparent Km of 167.3, 73.3, 64.0, or 47.6 microM for doxorubicin, daunorubicin, rubidazone, or aclacinomycin A, respectively. Superoxide formation by NADH dehydrogenase after doxorubicin treatment occurred with a pH optimum of 7.6 and was accompanied by the production of hydrogen peroxide. Furthermore, drug-related hydroxyl radical generation was detected in this enzyme system by the evolution of methane gas from dimethyl sulfoxide. Hydroxyl radical production proceeded only in the presence of superoxide anion, hydrogen peroxide, and trace amounts of iron or a chelate of iron and ethylenediaminetetraacetate and thus was probably the by-product of a transition metal-catalyzed Haber-Weiss reaction. The antitumor agents mitoxantrone and actinomycin D did not significantly enhance reactive oxygen metabolism by NADH dehydrogenase. These results suggest that the specific activation of the anthracycline antibiotics to free radicals by NADH dehydrogenase leads to the formation of a variety of reactive oxygen species that may contribute to the mitochondrial toxicity of these drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309369

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  Manganese superoxide dismutase: beyond life and death.

Authors:  Aaron K Holley; Sanjit Kumar Dhar; Yong Xu; Daret K St Clair
Journal:  Amino Acids       Date:  2010-05-08       Impact factor: 3.520

2.  Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel.

Authors:  James H Doroshow; Agnes Juhasz; Yun Ge; Susan Holbeck; Jiamo Lu; Smitha Antony; Yongzhong Wu; Guojian Jiang; Krishnendu Roy
Journal:  Biochem Pharmacol       Date:  2012-01-24       Impact factor: 5.858

3.  Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy.

Authors:  Kisuk Min; Oh-Sung Kwon; Ashley J Smuder; Michael P Wiggs; Kurt J Sollanek; Demetra D Christou; Jeung-Ki Yoo; Moon-Hyon Hwang; Hazel H Szeto; Andreas N Kavazis; Scott K Powers
Journal:  J Physiol       Date:  2015-02-23       Impact factor: 5.182

4.  4'-O-tetrahydropyranyl adriamycin (THP-ADM)-induced modifications of murine peritoneal macrophages.

Authors:  A Bravo-Cuellar; G Mathé; S Orbach-Arbouys
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

5.  Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin?

Authors:  D J Morré; C Kim; M Paulik; D M Morré; W P Faulk
Journal:  J Bioenerg Biomembr       Date:  1997-06       Impact factor: 2.945

6.  Effect of nitric oxide on the anticancer activity of the topoisomerase-active drugs etoposide and adriamycin in human melanoma cells.

Authors:  Birandra K Sinha; Ashutosh Kumar; Suchandra Bhattacharjee; Michael G Espey; Ronald P Mason
Journal:  J Pharmacol Exp Ther       Date:  2013-09-18       Impact factor: 4.030

7.  Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice.

Authors:  Qi-Yuan Liu; Benny K H Tan
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

8.  Protective effect of lipoic acid on adriamycin induced lipid peroxidation in rat kidney.

Authors:  Kumaravel Palanichamy Malarkodi; Andithangal Venkatesan Balachandar; Palaninathan Varalakshmi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

Review 9.  [Mitoxanthrone in the therapy of multiple sclerosis].

Authors:  B C Kieseier; R Gold; H-P Hartung
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

10.  Increased expression of cyclin E is associated with an increased resistance to doxorubicin in rat fibroblasts.

Authors:  A Sgambato; A Camerini; G Pani; R Cangiano; B Faraglia; G Bianchino; B De Bari; T Galeotti; A Cittadini
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.